prorx tirzepatide vs bpi tirzepatide Semaglutide Where to source glp-1 for

Not as powerful as tirzepatide or retatrutide in head-to-head data

GLP-1 medications are reshaping medical weight loss, with Tirzepatide leading the current market while Retatrutide emerges as a promising new contender

You should not change your medication schedule without consulting your healthcare provider

Sourcing quality concerns With retatrutide not yet FDA-approved, sourcing comes exclusively from research chemical suppliers

Administered as a once-weekly subcutaneous injection, tirzepatide is available in escalating doses (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg) to optimise glycaemic control and weight reduction whilst minimising gastrointestinal side effects

Bleeding-related events as adjacent gynaecological signals Although bleeding is not a vaginal mucosal endpoint, it is clinically adjacent because patients may describe spotting as vaginal bleeding and present alongside discharge/pain